The latex agglutination test kits market size has grown strongly in recent years. It will grow from $1.59 billion in 2025 to $1.69 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, expansion of diagnostic laboratory infrastructure, rising demand for rapid and early disease diagnosis, growing use of serological testing methods, increased healthcare focus on disease containment.
The latex agglutination test kits market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising demand for point-of-care diagnostic solutions, growing emphasis on early disease detection, increasing investments in diagnostic testing capabilities, expanding diagnostic access in emerging markets, rising need for rapid outbreak response tools. Major trends in the forecast period include growing demand for rapid diagnostic testing in clinical settings, increasing use of latex agglutination kits for infectious disease detection, rising adoption of point-of-care and quick turnaround diagnostic tests, expansion of latex agglutination testing in routine laboratory diagnostics, growing preference for cost-effective and easy-to-use diagnostic kits.
The surge in infectious diseases prevalence is anticipated to propel the expansion of the latex agglutination test kit market in the foreseeable future. Infectious diseases, stemming from pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions, are on the rise due to globalization, antimicrobial resistance, urbanization, climate change, and population growth. Latex agglutination tests serve as a rapid detection method for various infectious diseases, including bacterial and viral infections. For example, in November 2025, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported that in 2025, there were 266,165 CHIKVD cases and 118 deaths, representing a 35.2% decline from 2024, with Brazil in South America being the most affected. Hence, the escalating prevalence of infectious diseases is poised to fuel the latex agglutination test kit market's growth.
Leading companies in the latex agglutination test kits market are concentrating on introducing diagnostic technologies for foodborne illnesses and environmental contaminants. They aim to enhance disease diagnosis and gain a competitive advantage by offering rapid and user-friendly latex agglutination assays. These assays streamline pathogen detection, providing quick and straightforward identification in food and environmental samples. For instance, Gold Standard Diagnostics LLC launched Microgen rapid latex agglutination tests in March 2024. These tests, designed for confirming the diagnosis of specific pathogens such as Salmonella, Legionella, or Staphylococcus aureus colonies in food and environmental samples, offer rapid, easy, and cost-effective techniques. They serve as highly sensitive and specific alternatives to conventional culture procedures, completing within as little as two minutes and seamlessly integrating into laboratory workflows. Their simplicity allows labs to utilize them immediately without requiring specialized training or equipment.
In January 2023, Gold Standard Diagnostics LLC acquired Microgen Bioproducts Ltd., a UK-based biotechnology company specializing in diagnostic test kits and instruments, including latex agglutination tests for identifying bacteria. This acquisition aims to broaden Gold Standard Diagnostics LLC's portfolio of diagnostic test kits and instruments.
Major companies operating in the latex agglutination test kits market are Cardinal Health Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Hardy Diagnostics, Meridian Bioscience Inc., ELITechGroup, Fujirebio, Sekisui Diagnostics LLC, R-Biopharm AG, Savyon Diagnostics Ltd., Creative Diagnostics, ZeptoMetrix Corporation, HiMedia Laboratories, DIALAB GmbH, Arlington Scientific Inc., Atlas Medical GmbH, Pro Lab Diagnostics Inc., Gold Standard Diagnostics.
North America was the largest region in the latex agglutination test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the latex agglutination test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the latex agglutination test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have introduced cost pressures in the latex agglutination test kits market by increasing duties on imported reagents, latex particles, antibodies, and diagnostic consumables. These impacts have raised manufacturing and procurement costs, particularly affecting antigen and antibody detection kits, with north america and asia-pacific regions experiencing higher exposure due to reliance on imported raw materials. Diagnostic laboratories and hospitals have faced pricing pressures that influence procurement volumes. On the positive side, tariffs have encouraged local production of diagnostic reagents, supplier diversification, and regional manufacturing expansion, supporting long-term supply chain resilience.
The latex agglutination test kits market research report is one of a series of new reports that provides latex agglutination test kits market statistics, including latex agglutination test kits industry global market size, regional shares, competitors with a latex agglutination test kits market share, detailed latex agglutination test kits market segments, market trends and opportunities, and any further data you may need to thrive in the latex agglutination test kits industry. This latex agglutination test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Latex agglutination test kits serve as vital diagnostic tools in clinical settings, facilitating the identification of specific antigens or antibodies in biological materials. Operating on the principle of antigen-antibody interactions, these kits offer rapid and precise detection of various infectious diseases, thereby aiding in timely treatment and containment efforts. Due to their versatility and reliability, they are extensively utilized in laboratories.
The main product types of latex agglutination test kits include enzyme-linked immunosorbent assay, indirect fluorescent, hemagglutination inhibition, and serum neutralization. Enzyme-linked immunosorbent assay (ELISA) is a type of test wherein enzymes aid in detecting antibodies or antigens in a sample. Widely employed in laboratories for diagnosing diseases or monitoring health conditions such as infectious diseases or allergies, ELISA encompasses antibody detection and antigen testing. These tests are conducted on sample types such as blood, urine, cerebrospinal fluid, and others, and are applied across various settings including hospitals, diagnostic centers, and specialty clinics.
The latex agglutination test kits market consists of sales of microbial identification kits, serological test kits, and blood typing kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The latex agglutination test kits market size is expected to see strong growth in the next few years. It will grow to $2.13 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising demand for point-of-care diagnostic solutions, growing emphasis on early disease detection, increasing investments in diagnostic testing capabilities, expanding diagnostic access in emerging markets, rising need for rapid outbreak response tools. Major trends in the forecast period include growing demand for rapid diagnostic testing in clinical settings, increasing use of latex agglutination kits for infectious disease detection, rising adoption of point-of-care and quick turnaround diagnostic tests, expansion of latex agglutination testing in routine laboratory diagnostics, growing preference for cost-effective and easy-to-use diagnostic kits.
The surge in infectious diseases prevalence is anticipated to propel the expansion of the latex agglutination test kit market in the foreseeable future. Infectious diseases, stemming from pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions, are on the rise due to globalization, antimicrobial resistance, urbanization, climate change, and population growth. Latex agglutination tests serve as a rapid detection method for various infectious diseases, including bacterial and viral infections. For example, in November 2025, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported that in 2025, there were 266,165 CHIKVD cases and 118 deaths, representing a 35.2% decline from 2024, with Brazil in South America being the most affected. Hence, the escalating prevalence of infectious diseases is poised to fuel the latex agglutination test kit market's growth.
Leading companies in the latex agglutination test kits market are concentrating on introducing diagnostic technologies for foodborne illnesses and environmental contaminants. They aim to enhance disease diagnosis and gain a competitive advantage by offering rapid and user-friendly latex agglutination assays. These assays streamline pathogen detection, providing quick and straightforward identification in food and environmental samples. For instance, Gold Standard Diagnostics LLC launched Microgen rapid latex agglutination tests in March 2024. These tests, designed for confirming the diagnosis of specific pathogens such as Salmonella, Legionella, or Staphylococcus aureus colonies in food and environmental samples, offer rapid, easy, and cost-effective techniques. They serve as highly sensitive and specific alternatives to conventional culture procedures, completing within as little as two minutes and seamlessly integrating into laboratory workflows. Their simplicity allows labs to utilize them immediately without requiring specialized training or equipment.
In January 2023, Gold Standard Diagnostics LLC acquired Microgen Bioproducts Ltd., a UK-based biotechnology company specializing in diagnostic test kits and instruments, including latex agglutination tests for identifying bacteria. This acquisition aims to broaden Gold Standard Diagnostics LLC's portfolio of diagnostic test kits and instruments.
Major companies operating in the latex agglutination test kits market are Cardinal Health Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Hardy Diagnostics, Meridian Bioscience Inc., ELITechGroup, Fujirebio, Sekisui Diagnostics LLC, R-Biopharm AG, Savyon Diagnostics Ltd., Creative Diagnostics, ZeptoMetrix Corporation, HiMedia Laboratories, DIALAB GmbH, Arlington Scientific Inc., Atlas Medical GmbH, Pro Lab Diagnostics Inc., Gold Standard Diagnostics.
North America was the largest region in the latex agglutination test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the latex agglutination test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the latex agglutination test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have introduced cost pressures in the latex agglutination test kits market by increasing duties on imported reagents, latex particles, antibodies, and diagnostic consumables. These impacts have raised manufacturing and procurement costs, particularly affecting antigen and antibody detection kits, with north america and asia-pacific regions experiencing higher exposure due to reliance on imported raw materials. Diagnostic laboratories and hospitals have faced pricing pressures that influence procurement volumes. On the positive side, tariffs have encouraged local production of diagnostic reagents, supplier diversification, and regional manufacturing expansion, supporting long-term supply chain resilience.
The latex agglutination test kits market research report is one of a series of new reports that provides latex agglutination test kits market statistics, including latex agglutination test kits industry global market size, regional shares, competitors with a latex agglutination test kits market share, detailed latex agglutination test kits market segments, market trends and opportunities, and any further data you may need to thrive in the latex agglutination test kits industry. This latex agglutination test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Latex agglutination test kits serve as vital diagnostic tools in clinical settings, facilitating the identification of specific antigens or antibodies in biological materials. Operating on the principle of antigen-antibody interactions, these kits offer rapid and precise detection of various infectious diseases, thereby aiding in timely treatment and containment efforts. Due to their versatility and reliability, they are extensively utilized in laboratories.
The main product types of latex agglutination test kits include enzyme-linked immunosorbent assay, indirect fluorescent, hemagglutination inhibition, and serum neutralization. Enzyme-linked immunosorbent assay (ELISA) is a type of test wherein enzymes aid in detecting antibodies or antigens in a sample. Widely employed in laboratories for diagnosing diseases or monitoring health conditions such as infectious diseases or allergies, ELISA encompasses antibody detection and antigen testing. These tests are conducted on sample types such as blood, urine, cerebrospinal fluid, and others, and are applied across various settings including hospitals, diagnostic centers, and specialty clinics.
The latex agglutination test kits market consists of sales of microbial identification kits, serological test kits, and blood typing kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Latex Agglutination Test Kits Market Characteristics
3. Latex Agglutination Test Kits Market Supply Chain Analysis
4. Global Latex Agglutination Test Kits Market Trends and Strategies
5. Latex Agglutination Test Kits Market Analysis of End Use Industries
7. Global Latex Agglutination Test Kits Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Latex Agglutination Test Kits Total Addressable Market (TAM) Analysis for the Market
9. Latex Agglutination Test Kits Market Segmentation
10. Latex Agglutination Test Kits Market Regional and Country Analysis
11. Asia-Pacific Latex Agglutination Test Kits Market
12. China Latex Agglutination Test Kits Market
13. India Latex Agglutination Test Kits Market
14. Japan Latex Agglutination Test Kits Market
15. Australia Latex Agglutination Test Kits Market
16. Indonesia Latex Agglutination Test Kits Market
17. South Korea Latex Agglutination Test Kits Market
18. Taiwan Latex Agglutination Test Kits Market
19. South East Asia Latex Agglutination Test Kits Market
20. Western Europe Latex Agglutination Test Kits Market
21. UK Latex Agglutination Test Kits Market
22. Germany Latex Agglutination Test Kits Market
23. France Latex Agglutination Test Kits Market
24. Italy Latex Agglutination Test Kits Market
25. Spain Latex Agglutination Test Kits Market
26. Eastern Europe Latex Agglutination Test Kits Market
27. Russia Latex Agglutination Test Kits Market
28. North America Latex Agglutination Test Kits Market
29. USA Latex Agglutination Test Kits Market
30. Canada Latex Agglutination Test Kits Market
31. South America Latex Agglutination Test Kits Market
32. Brazil Latex Agglutination Test Kits Market
33. Middle East Latex Agglutination Test Kits Market
34. Africa Latex Agglutination Test Kits Market
36. Latex Agglutination Test Kits Market Competitive Landscape and Company Profiles
37. Latex Agglutination Test Kits Market Other Major and Innovative Companies
40. Latex Agglutination Test Kits Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Latex Agglutination Test Kits Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses latex agglutination test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for latex agglutination test kits? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The latex agglutination test kits market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Latex Agglutination Test Kits; Latex-Enhanced Agglutination Test Kits; Rapid Slide Latex Agglutination Kits; Automated Latex Agglutination Reagents2) By Test Type: Antigen Detection Latex Agglutination Tests; Antibody Detection Latex Agglutination Tests
3) By Sample Type: Blood; Serum; Plasma; Cerebrospinal Fluid (CSF); Urine; Other Sample Types
4) By Application: Infectious Disease Diagnosis; Bacterial Pathogen Detection; Fungal Pathogen Detection; Parasitic Infection Detection; Other Diagnostic Applications
5) By End User: Hospitals; Diagnostic Laboratories; Specialty Clinics; Academic and Research Laboratories
Subsegments:
1) By Latex Agglutination Test Kits: Manual Latex Agglutination Test Kits; Ready-to-Use Latex Agglutination Kits; Multiplex Latex Agglutination Test Kits; Quality-Control Latex Agglutination Kits2) By Latex-Enhanced Agglutination Test Kits: Particle-Enhanced Immuno-Latex Assay Kits; High-Sensitivity Latex-Enhanced Agglutination Kits; Quantitative Latex-Enhanced Agglutination Kits; Turbidimetric Latex-Enhanced Agglutination Kits
3) By Rapid Slide Latex Agglutination Kits: One-Step Slide Latex Agglutination Kits; Point-of-Care Slide Agglutination Kits; Disposable Card-Based Latex Agglutination Kits; Rapid Screening Latex Agglutination Kits
4) By Automated Latex Agglutination Reagents: Analyzer-Compatible Latex Agglutination Reagents; Turbidimetric Automated Latex Reagents; Nephelometric Latex Agglutination Reagents; High-Throughput Automated Latex Reagent Systems
Companies Mentioned: Cardinal Health Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson and Company; bioMérieux SA; Bio-Rad Laboratories Inc.; Hardy Diagnostics; Meridian Bioscience Inc.; ELITechGroup; Fujirebio; Sekisui Diagnostics LLC; R-Biopharm AG; Savyon Diagnostics Ltd.; Creative Diagnostics; ZeptoMetrix Corporation; HiMedia Laboratories; DIALAB GmbH; Arlington Scientific Inc.; Atlas Medical GmbH; Pro Lab Diagnostics Inc.; Gold Standard Diagnostics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Latex Agglutination Test Kits market report include:- Cardinal Health Inc.
- Thermo Fisher Scientific Inc.
- Becton Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Hardy Diagnostics
- Meridian Bioscience Inc.
- ELITechGroup
- Fujirebio
- Sekisui Diagnostics LLC
- R-Biopharm AG
- Savyon Diagnostics Ltd.
- Creative Diagnostics
- ZeptoMetrix Corporation
- HiMedia Laboratories
- DIALAB GmbH
- Arlington Scientific Inc.
- Atlas Medical GmbH
- Pro Lab Diagnostics Inc.
- Gold Standard Diagnostics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.69 Billion |
| Forecasted Market Value ( USD | $ 2.13 Billion |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
